TAS-116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T-cell leukemia. - Ikebe E; Shimosaki S; Hasegawa H; Iha H; Tsukamoto Y; Wang Y; Sasaki D; Imaizumi Y; Miyazaki Y; Yanagihara K; Hamaguchi I; Morishita K (Cancer science, 2022)